In the latest updates from Wall Street, a variety of research calls are influencing market movements, emphasizing significant upgrades and downgrades that investors should monitor closely.
Among the top upgrades, Citizens has taken the initiative to enhance Stryker’s rating from Market Perform to Outperform, establishing a price target of $440. The firm noted that the stock’s current valuation presents a compelling opportunity for investors.
Barclays has upgraded Cummins from Equal Weight to Overweight, setting a new price target of $546, a notable increase from the previous $515. This upgrade is attributed to the introduction of new emissions regulations for 2027, decreasing research and development expenses, and the company’s strong position in the power generation sector, which is aiding in bridging the earnings gap.
Wells Fargo has also elevated its rating for Generac, moving it from Equal Weight to Overweight with a revised price target of $195, up from $186. The firm highlighted that the recent dip in share prices presents a unique opportunity related to the company’s data center growth potential.
In a similar vein, JPMorgan upgraded Paccar from Neutral to Overweight, adjusting the price target to $133 from $108. Analysts pointed to a recent proclamation affecting tariffs that is expected to mitigate most of Paccar’s tariff-related challenges moving into next year.
Meanwhile, Keefe Bruyette has upgraded Bain Capital Specialty Finance, changing its rating from Market Perform to Outperform, while maintaining a price target of $16. The firm indicated that the current share performance creates an attractive entry point for potential investors.
On the downgrade front, Wedbush has reduced Lyft’s rating from Neutral to Underperform, with a new price target set at $16, down from $20. This decision stems from concerns regarding Lyft’s vulnerability to disruptions from autonomous vehicles, particularly due to its U.S. ridesharing market exposure and a lack of diversified offerings.
JPMorgan has downgraded Lockheed Martin from Overweight to Neutral, now setting the price target at $515, previously $465. The downgrade reflects the firm’s outlook for the aerospace and defense sector, where future cash flow estimates fall below consensus expectations.
Raymond James has altered Allegiant Travel’s rating from Strong Buy to Outperform, with an adjusted price target of $98, increasing from $78. This change follows a recent surge in share prices, leading to concerns about valuations ahead of the company’s Q4 report.
Deutsche Bank has downgraded Elevance Health from Buy to Hold, establishing a price target of $320, which is a decrease from $332. The firm cited reduced estimates and a challenging macroeconomic environment as key factors in this decision.
Lastly, Williams Trading downgraded Birkenstock from Buy to Hold, lowering the price target from $75 to $51 after the company’s earnings report. The firm expressed concerns regarding the lack of clarity from management, indicating that it complicates ownership of the stock.
Investors are advised to keep a close watch on these ratings as they navigate market conditions influenced by these strategic calls by leading financial firms.
